Non-invasive automatic light-gathering photoacoustic blood glucose measuring system

Through the non-invasive automatic light-concentrating photoacoustic blood glucose measurement system, the laser probe and ultrasonic conversion device combined with signal processing algorithms, the problems of discomfort and limited accuracy of blood collection in existing blood glucose measurement devices are solved, and the problem of blood collection in multiple body positions is realized. Accurate and real-time blood sugar measurements improve user experience and quality of measurement results.

CN118924294APending Publication Date: 2024-11-12EAST CHINA UNIV OF SCI & TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411124101.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-16
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

Existing blood glucose measurement devices require blood collection, which are uncomfortable to use, with limited accuracy and real-time limitations, and cannot be used in locations other than fingertips. There are accuracy and real-time problems with non-invasive methods such as electrode sheet measurement and Raman method.

Method used

The photoacoustic blood sugar measurement system adopts a non-invasive automatic concentration, including a laser probe, an ultrasonic conversion device and a microcontroller, uses a medium-wave infrared laser and an automatic waveguide light concentrator to penetrate the skin, and combines signal processing algorithms and wireless communication to achieve blood sugar Accurate and real-time measurement of content.

Benefits of technology

It realizes non-invasive, real-time and accurate blood sugar measurements, and can be used in multiple physical locations, improving the direction and accuracy of user experience and measurement results, and meeting the needs of regular and timed monitoring.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924294A_ABST
    Figure CN118924294A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of blood glucose measurement, and particularly relates to a noninvasive automatic light-gathering photoacoustic blood glucose measurement system which comprises a laser probe, an ultrasonic conversion device and a microcontroller. The signal output end of the microcontroller is connected with the laser probe, the signal output end of the ultrasonic wave conversion device is connected with the microcontroller, and the laser probe comprises a laser transmitter and an automatic waveguide condensation device. The photoacoustic method principle is used, blood sampling is not needed, preparation work before measurement is little, the real-time performance of the measurement result is high, damage to the skin of a measured user cannot be caused, and consumable items are not needed. The laser probe uses an ultrasonic waveguide automatic condensation device, can effectively penetrate through the skin and directly reach deep blood vessels, and realizes measurement of the content of glucose in blood instead of body fluid and skin interstitial fluid. The microprocessor can screen the collected pressure wave signals and find out the signal returned from the deepest position.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of blood sugar measurement, in particular to a non-invasive automatic focusing photoacoustic blood sugar measurement system. Background Art

[0002] The blood glucose measuring devices currently on the market require blood sampling from the finger and use enzyme reactions to obtain the glucose content in the blood. This is an invasive measuring device. For diabetic patients or other users who require blood glucose monitoring, this type of invasive measurement method is uncomfortable to use, and the purchase of consumables requires additional financial expenditure. The complexity of manual blood sampling is also not conducive to regular blood glucose monitoring.

[0003] In addition to the defects in user experience, the accuracy and real-time performance of such invasive measurement devices are also restricted by the length of the collection needle. Shorter collection needles can only collect surface blood, and there is a high probability that interstitial fluid of the skin will be collected, thus affecting the accuracy of the measurement results. Therefore, such invasive blood glucose measurement devices can only be used for fingertip measurements, and cannot be used for measurements in the arms, thighs, chest, and near the heart. In addition, the fingertips are located at the end of the human blood circulation system, and real-time performance cannot be guaranteed. The limitations of the measurement position also limit the versatility of such invasive measurement devices.

[0004] Among the non-invasive blood sugar measurement methods currently under research, there are two methods: the sweat method based on electrode measurement and the Raman method based on infrared spectroscopy. The electrode measurement of glucose content in sweat can reflect the changing trend of blood sugar, but it cannot accurately reflect the exact content value of blood sugar, and its real-time performance is poor. It takes a period of time to get the changes in blood sugar. The Raman method can measure a narrow range of blood sugar, and the optical method is very easily affected by ambient light, with poor signal quality and limited application scenarios. Summary of the invention

[0005] The purpose of the present invention is to provide a non-invasive automatic focusing photoacoustic blood glucose measurement system to solve the problem that the electrode sheet proposed in the above background technology can measure the glucose content in sweat, which can reflect the change trend of blood glucose, but cannot accurately reflect the accurate content value of blood glucose, and has poor real-time performance, and requires a period of time to obtain the change of blood glucose. The Raman method can measure a narrow range of blood glucose, and the optical method is very easily affected by ambient light, has poor signal quality, and has limited application scenarios.

[0006] To achieve the above object, the present invention provides the following technical solution: a non-invasive automatic focusing photoacoustic blood glucose measurement system, comprising: a laser probe, an ultrasonic conversion device and a microcontroller;

[0007] The signal output end of the microcontroller is connected to the laser probe, and the signal output end of the ultrasonic conversion device is connected to the microcontroller;

[0008] The laser probe includes a laser transmitter and an automatic waveguide focusing device. The laser transmitter emits laser, which is filtered by the automatic waveguide focusing device to obtain a target laser, which is injected into the skin. The ultrasonic converter and the laser probe are located on the same side of the skin. The ultrasonic converter receives the pressure wave signal returned by the skin, and the pressure wave signal is output to a microcontroller.

[0009] Preferably, the laser emitter uses a wave number of 1080cm -1 of mid-wave infrared.

[0010] Preferably, the pressure wave signal is converted from an analog signal to a digital signal by an analog-to-digital converter and sent to a microcontroller in a wired communication mode for signal processing.

[0011] Preferably, the automatic waveguide focusing device includes a backing layer, a gold electrode, a piezoelectric material layer, a gold electrode, a matching layer, a gold electrode and an acoustic holographic mirror which are arranged in sequence from top to bottom.

[0012] Preferably, a signal processing algorithm is executed in the microcontroller to perform principal component analysis and time gating on the digital signal. The time gating algorithm determines the time window length based on the Hilbert transform, first divides the signal by the time window, and filters out the signal components returned from the deepest position. Finally, the time gating algorithm first performs principal component analysis on these filtered signals, and then uses partial least squares regression to perform linear decomposition on the signal spectrum. Through the leave-one-out cross-validation method, each spectrum used for glucose measurement is eliminated once to determine the main component that can represent the spectral change, that is, the blood glucose content in the tissue.

[0013] Preferably, after obtaining the value of the blood sugar content, the microcontroller sends the value of the blood sugar content to a terminal with a human-computer interaction interface through wireless communication means.

[0014] Preferably, the wireless communication means is low-power Bluetooth.

[0015] Compared with the prior art, the present invention has the following beneficial effects:

[0016] Using the principle of photoacoustic method, there is no need for blood sampling, less preparation work before measurement, the measurement results are highly real-time, and it will not cause damage to the skin of the user being measured, and no consumables are required.

[0017] The laser probe uses an ultrasonic waveguide automatic focusing device, which can effectively penetrate the skin and reach deep blood vessels, and measure the glucose content in the blood rather than in body fluids and skin interstitial fluid. Compared with the method of using electrodes to measure the glucose concentration in sweat, it has a fast response speed and good real-time performance. In addition, the waveguide focusing device realizes the controllable light propagation of medium-wave infrared in scattering media, concentrating the energy of the laser in one place. In addition to improving the directionality of the measurement results, it also enhances the thermal energy concentration of light energy converted into heat energy, and improves the quality and intensity of the pressure wave signal generated by heat energy.

[0018] The microprocessor can filter the collected pressure wave signals to find the signals returned from the deepest depth. The algorithm will further use partial least squares regression to linearly decompose the signal spectrum to find the signal components directly related to blood sugar content. Compared with directly substituting the peak-to-peak value into the empirical formula for fitting, it effectively improves the accuracy of the measurement results and reflects the trend of blood sugar changes.

[0019] The system has wireless communication means, combined with medium-wave infrared, waveguide automatic focusing device, signal screening algorithm and other methods, which broadens the available measurement positions of the device on the user's body. When using the system proposed by the present invention, it is not necessary to stick to the limited measurement positions with many surface blood vessels for measurement and reading. Among them, the wireless communication means also makes the system miniaturized, improves the user's experience in daily life, and meets the needs of regular and timed monitoring of blood sugar concentration. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 It is a structural schematic diagram of the present invention;

[0021] Figure 2 It is a schematic diagram of the split structure of the automatic waveguide focusing device of the present invention;

[0022] Figure 3 It is a schematic diagram of the structure of the automatic waveguide focusing device of the present invention when in use;

[0023] Figure 4 Schematic diagram of the depth determination screening method of the present invention. DETAILED DESCRIPTION

[0024] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0025] In the description of the present invention, it is necessary to understand that the terms "upper", "lower", "front", "back", "left", "right", "top", "bottom", "inside", "outside", etc., indicating the orientation or position relationship are based on the orientation or position relationship shown in the drawings, and are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as a limitation on the present invention.

[0026] Embodiment 1:

[0027] See also Figure 1-4 ,The present invention provides a technical solution: a non-invasive automatic focusing photoacoustic blood glucose measurement system, comprising: a laser probe, an ultrasonic conversion device and a microcontroller;

[0028] The signal output end of the microcontroller is connected to the laser probe, and the signal output end of the ultrasonic conversion device is connected to the microcontroller. The laser probe includes a laser transmitter and an automatic waveguide focusing device. The laser transmitter emits laser, and the laser is filtered by the automatic waveguide focusing device to obtain the target laser, which is injected into the skin. The ultrasonic conversion device and the laser probe are located on the same side of the skin. The ultrasonic conversion device receives the pressure wave signal returned by the skin, and the pressure wave signal is output to the microcontroller. The laser transmitter uses a wave number of 1080cm -1 The medium-wave infrared ray is converted from an analog signal to a digital signal by an analog-to-digital converter, and is sent to a microcontroller for signal processing in a wired transmission communication mode. The automatic waveguide focusing device includes a backing layer, a gold electrode, a piezoelectric material layer, a gold electrode, a matching layer, a gold electrode and an acoustic holographic mirror arranged in sequence from top to bottom. The signal processing algorithm is executed in the microcontroller to perform principal component analysis and time gating on the digital signal. The time gating algorithm determines the time window length based on the Hilbert transform, first divides the signal by the time window, and filters out the signal component returned from the deepest position. Finally, the time gating algorithm performs principal component analysis on these filtered signals, and then uses partial least squares regression to perform linear decomposition on the signal spectrum. Through the leave-one-out cross-validation method, each spectrum used for glucose measurement is eliminated once to determine the main component that can represent the spectral change, that is, the blood glucose content in the tissue. After obtaining the value of the blood glucose content, the microcontroller sends the value of the blood glucose content to a terminal with a human-computer interaction interface through wireless communication means:, and the wireless communication means is low-power Bluetooth.

[0029] Analysis of the above content: There is a laser probe with a laser transmitter and an automatic waveguide focusing device, as well as an ultrasonic conversion device for receiving sound waves and a microcontroller for signal processing. The laser transmitter in the laser probe uses a wave number of 1080cm -1The medium-wave infrared passes through the automatic waveguide focusing device to irradiate the laser onto the skin. Considering the difference between the speed of light and the speed of sound, the automatic waveguide focusing device uses ultrasound waves of a specific wavelength to inject into the skin in advance of the laser, forming a beam guiding effect and focusing the laser within a certain range. The light energy is converted into heat energy to produce molecular motion, and heat is released in a non-radiative form, causing local temperature rise, tissue volume expansion, and pressure waves. The ultrasonic converter placed on the same side of the skin as the probe can receive the pressure wave signal returned by the skin.

[0030] The pressure wave signal is converted from an analog signal to a digital signal through an analog-to-digital converter and sent to the system's microcontroller for signal processing via wired transmission. The signal processing algorithm is executed in the microcontroller to perform principal component analysis and time gating on the digitized pressure wave signal. The time gating algorithm determines the time window length based on the Hilbert transform. The signal is first divided by the time window to filter out the signal components returned from the deepest position. Finally, the algorithm first performs principal component analysis on these filtered signals, and then uses partial least squares regression to perform linear decomposition on the signal spectrum. Through the leave-one-out cross-validation method, each spectrum used for glucose measurement is eliminated once to determine the main component that can represent the spectral change, that is, the blood glucose content in the tissue.

[0031] After obtaining the blood sugar content value, the microcontroller sends the value to a terminal with a human-computer interaction interface through wireless communication means: low-power Bluetooth.

[0032] The above shows and describes the basic principles and main features of the present invention and the advantages of the present invention. For those skilled in the art, it is obvious that the present invention is not limited to the details of the above exemplary embodiments, and the present invention can be implemented in other specific forms without departing from the spirit or basic features of the present invention; therefore, no matter from which point of view, the embodiments should be regarded as exemplary and non-restrictive. The scope of the present invention is limited by the attached claims rather than the above description. Therefore, it is intended to include all changes within the meaning and scope of the equivalent elements of the claims in the present invention, and any figure marks in the claims should not be regarded as limiting the claims involved.

[0033] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A non-invasive automatic focusing photoacoustic blood glucose measurement system, characterized in that: Including: laser probe, ultrasonic conversion device and microcontroller; The signal output end of the microcontroller is connected to the laser probe, and the signal output end of the ultrasonic conversion device is connected to the microcontroller; The laser probe includes a laser transmitter and an automatic waveguide focusing device. The laser transmitter emits laser, which is filtered by the automatic waveguide focusing device to obtain a target laser, which is injected into the skin. The ultrasonic converter and the laser probe are located on the same side of the skin. The ultrasonic converter receives the pressure wave signal returned by the skin, and the pressure wave signal is output to a microcontroller.

2. The non-invasive automatic focusing photoacoustic blood glucose measurement system according to claim 1, characterized in that: The laser transmitter uses a wave number of 1080cm -1 of mid-wave infrared.

3. The non-invasive automatic light-focusing photoacoustic blood glucose measurement system according to claim 1, characterized in that: The pressure wave signal is converted from an analog signal to a digital signal by an analog-to-digital converter and sent to a microcontroller in a wired communication mode for signal processing.

4. The non-invasive automatic focusing photoacoustic blood glucose measurement system according to claim 1, characterized in that: The automatic waveguide focusing device comprises a backing layer, a gold electrode, a piezoelectric material layer, a gold electrode, a matching layer, a gold electrode and an acoustic holographic mirror which are arranged in sequence from top to bottom.

5. The non-invasive automatic focusing photoacoustic blood glucose measurement system according to claim 3, characterized in that: The signal processing algorithm is executed in the microcontroller to perform principal component analysis and time gating on the digital signal. The time gating algorithm determines the time window length based on the Hilbert transform. The signal is first divided by the time window to filter out the signal components returned from the deepest position. Finally, the time gating algorithm first performs principal component analysis on these filtered signals, and then uses partial least squares regression to perform linear decomposition on the signal spectrum. Through the leave-one-out cross-validation method, each spectrum used for glucose measurement is eliminated once to determine the main component that can represent the spectral change, that is, the blood glucose content in the tissue.

6. The non-invasive automatic light-focusing photoacoustic blood glucose measurement system according to claim 5, characterized in that: After obtaining the value of the blood sugar content, the microcontroller sends the value of the blood sugar content to a terminal with a human-computer interaction interface through wireless communication means.

7. The non-invasive automatic light-focusing photoacoustic blood glucose measurement system according to claim 6, characterized in that: The wireless communication means is low-power Bluetooth.